Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 869367102 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Kynam Capital Management, LP
13G/A
Amendment 1
|
5.3% |
5/15/2026
Event 3/31/2026
|
|
| Kynam Capital Management, LP | 5.3% | ||
| Kynam Capital Management GP, LLC | 5.3% | ||
| Yue Tang | 5.3% | ||
|
Suvretta Capital Management, LLC
13G/A
Amendment 5
|
0% |
2/13/2026
Event 12/31/2025
|
|
| Suvretta Capital Management, LLC | 0% | ||
| Averill Master Fund, Ltd. | 0% | ||
| Aaron Cowen | 0% | ||
|
Suvretta Capital Management, LLC
13G/A
Amendment 5
|
0% |
2/13/2026
Event 12/31/2025
|
|
| Suvretta Capital Management, LLC | 0% | ||
| Averill Master Fund, Ltd. | 0% | ||
| Aaron Cowen | 0% | ||
|
Affinity Asset Advisors, LLC
13G
|
7.8% |
10/23/2025
Event 10/16/2025
|
|
| Affinity Healthcare Fund, LP | 7.8% | ||
| Affinity Asset Advisors, LLC | 7.8% | ||
|
RA Capital Management, L.P.
13G/A
Amendment 1
|
0% |
8/14/2025
Event 6/30/2025
|
|
| RA Capital Management, L.P. | 0% | ||
| Peter Kolchinsky | 0% | ||
| Rajeev Shah | 0% | ||
| RA Capital Healthcare Fund, L.P. | 0% | ||
|
Suvretta Capital Management, LLC
13G/A
Amendment 4
|
7.7% |
8/13/2025
Event 6/30/2025
|
|
| Suvretta Capital Management, LLC | 7.7% | ||
| Averill Master Fund, Ltd. | 7.7% | ||
| Aaron Cowen | 7.7% | ||
| Vanguard Group Inc 13G/A Amendment 2 | 4.9% |
7/29/2025
Event 6/30/2025
|
|
| BlackRock, Inc. 13G/A Amendment 5 | 2.5% |
7/16/2025
Event 6/30/2025
|
|
|
Millennium Management LLC
13G
|
5.6% |
6/30/2025
Event 6/27/2025
|
|
| Millennium Management LLC | 5.6% | ||
| Millennium Group Management LLC | 5.6% | ||
| Israel A. Englander | 5.6% | ||
|
Kynam Capital Management, LP
13G
|
6.4% |
5/15/2025
Event 3/31/2025
|
|
| Kynam Capital Management, LP | 6.4% | ||
| Kynam Capital Management GP, LLC | 6.4% | ||
| Yue Tang | 6.4% | ||
| BlackRock, Inc. 13G/A Amendment 4 | 7.3% |
4/17/2025
Event 3/31/2025
|
|
|
RA Capital Management, L.P.
13G
|
5.3% |
4/4/2025
Event 3/28/2025
|
|
| RA Capital Management, L.P. | 5.3% | ||
| Peter Kolchinsky | 5.3% | ||
| Rajeev Shah | 5.3% | ||
| RA Capital Healthcare Fund, L.P. | 5.3% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 3 | 153 | $5.08 k |
| 2026 Q1 | 7 | 290 k | $7.22 M |
| 2025 Q4 | 7 | 290 k | $3.36 M |
| 2025 Q3 | 89 | 53.5 M | $46.4 M |
| 2025 Q2 | 105 | 55.8 M | $39.8 M |
| 2025 Q1 | 118 | 61.5 M | $40.0 M |
| 2024 Q4 | 127 | 63.9 M | $118 M |
| 2024 Q3 | 136 | 62.6 M | $216 M |
| 2024 Q2 | 125 | 63.5 M | $186 M |
| 2024 Q1 | 123 | 54.6 M | $308 M |
| 2023 Q4 | 120 | 57.0 M | $245 M |
| 2023 Q3 | 112 | 56.0 M | $194 M |
| 2023 Q2 | 123 | 54.1 M | $252 M |
| 2023 Q1 | 119 | 53.7 M | $248 M |
| 2022 Q4 | 127 | 51.8 M | $419 M |
| 2022 Q3 | 116 | 51.7 M | $287 M |
| 2022 Q2 | 119 | 46.2 M | $241 M |
| 2022 Q1 | 116 | 41.7 M | $342 M |
| 2021 Q4 | 122 | 40.3 M | $599 M |
| 2021 Q3 | 122 | 39.8 M | $753 M |
| 2021 Q2 | 128 | 41.2 M | $767 M |
| 2021 Q1 | 147 | 44.4 M | $1.05 B |
| 2020 Q4 | 142 | 39.5 M | $857 M |
| 2020 Q3 | 88 | 31.2 M | $313 M |
| 2020 Q2 | 81 | 24.4 M | $189 M |
| 2020 Q1 | 62 | 11.9 M | $122 M |
| 2019 Q4 | 66 | 11.7 M | $129 M |
| 2019 Q3 | 61 | 11.1 M | $101 M |
| 2019 Q2 | 59 | 11.8 M | $134 M |
| 2019 Q1 | 51 | 11.2 M | $128 M |
| 2018 Q4 | 45 | 10.9 M | $97.7 M |
| 2018 Q3 | 34 | 9.23 M | $137 M |